跳至主要内容
临床试验/NCT03072836
NCT03072836Unknown不适用

Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2017年3月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
108
试验地点
1
主要终点
Microbiota analysis

研究概览

简要总结

The FLORACROHN project aims to compare gut microbiota of patients suffering from Crohn's disease (CD) associated or not to spondylarthritis (SpA).

3 groups of patients will be analyzed: patients suffering from CD alone, patients suffering from SpA alone, patients suffering from CD and SpA.

Fecal microbiota will be determined by 16SRNA gene sequencing.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with Crohn's disease and axial spondyloarthritis according to the criteria below.
  • •Patients with Crohn's disease (CT patients) diagnosed according to clinical, biological, radiological, endoscopic and / or histological criteria for 3 months. With diagnosis of spondyloarthritis exclusion on modified ASAS and / or New York criteria.
  • •Patients with axial spondyloarthritis (SpA patients) diagnosed according to the modified ASAS and / or New York criteria with exclusion diagnosis of Crohn's disease.
  • •Patient with the capacity to give free and informed consent.

排除标准

  • •Antecedent of colonic resection
  • •Antibiotic or colonic colonoscopy preparation in the 8 weeks prior to stool collection (against temporary indication = collection possible before colic preparation or on the first saddle after the start of the colic preparation).
  • •Ostomy at time of collection
  • •extreme diet
  • •unbalanced diabetes
  • •Patient under guardianship, under curatorship or under safeguard of justice

研究组 & 干预措施

CD alone

Experimental

干预措施: analysing microbiota (Other)

SPA alone

Experimental

干预措施: analysing microbiota (Other)

CD + SPA

Experimental

干预措施: analysing microbiota (Other)

结局指标

主要结局

Microbiota analysis

时间窗: 6 months after last patient inclusion

16SRNA gene sequencing

次要结局

未报告次要终点

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pr Laurent PEYRIN BIROULET

Professor

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验

Study of Gut Microbiota in Crohn's Disease Patients... | 临床试验